In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis

Nicole C. Kleinstreuer, David J. Dix, Keith A. Houck, Robert J. Kavlock, Thomas B. Knudsen, Matthew T. Martin, Katie B. Paul, David M. Reif, Kevin M. Crofton, Kerry Hamilton, Ronald Hunter, Imran Shah, Richard S. Judson

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Thousands of untested chemicals in the environment require efficient characterization of carcinogenic potential in humans. A proposed solution is rapid testing of chemicals using in vitro high-throughput screening (HTS) assays for targets in pathways linked to disease processes to build models for priority setting and further testing. We describe a model for predicting rodent carcinogenicity based on HTS data from 292 chemicals tested in 672 assays mapping to 455 genes. All data come from the EPA ToxCast project. The model was trained on a subset of 232 chemicals with in vivo rodent carcinogenicity data in the Toxicity Reference Database (ToxRefDB). Individual HTS assays strongly associated with rodent cancers in ToxRefDB were linked to genes, pathways, and hallmark processes documented to be involved in tumor biology and cancer progression. Rodent liver cancer endpoints were linked to well-documented pathways such as peroxisome proliferator-activated receptor signaling and TP53 and novel targets such as PDE5A and PLAUR. Cancer hallmark genes associated with rodent thyroid tumors were found to be linked to human thyroid tumors and autoimmune thyroid disease. A model was developed in which these genes/pathways function as hypothetical enhancers or promoters of rat thyroid tumors, acting secondary to the key initiating event of thyroid hormone disruption. A simple scoring function was generated to identify chemicals with significant in vitro evidence that was predictive of in vivo carcinogenicity in different rat tissues and organs. This scoring function was applied to an external test set of 33 compounds with carcinogenicity classifications from the EPA's Office of Pesticide Programs and successfully (p = 0.024) differentiated between chemicals classified as "possible"/"probable"/"likely" carcinogens and those designated as "not likely" or with "evidence of noncarcinogenicity." This model represents a chemical carcinogenicity prioritization tool supporting targeted testing and functional validation of cancer pathways.

Original languageEnglish (US)
Pages (from-to)40-55
Number of pages16
JournalToxicological Sciences
Volume131
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Fingerprint

Rodentia
Carcinogenesis
Tumors
Genes
Neoplasms
High-Throughput Screening Assays
Assays
Screening
Thyroid Gland
Throughput
Toxicity
Rats
Testing
Databases
Peroxisome Proliferator-Activated Receptors
Neoplasm Genes
Thyroid Diseases
Liver Neoplasms
In Vitro Techniques
Thyroid Hormones

Keywords

  • Bioinformatics.
  • Cancer hallmarks
  • Carcinogenesis
  • In vitro and alternatives
  • Predictive toxicology

ASJC Scopus subject areas

  • Toxicology

Cite this

Kleinstreuer, N. C., Dix, D. J., Houck, K. A., Kavlock, R. J., Knudsen, T. B., Martin, M. T., ... Judson, R. S. (2013). In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. Toxicological Sciences, 131(1), 40-55. https://doi.org/10.1093/toxsci/kfs285

In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. / Kleinstreuer, Nicole C.; Dix, David J.; Houck, Keith A.; Kavlock, Robert J.; Knudsen, Thomas B.; Martin, Matthew T.; Paul, Katie B.; Reif, David M.; Crofton, Kevin M.; Hamilton, Kerry; Hunter, Ronald; Shah, Imran; Judson, Richard S.

In: Toxicological Sciences, Vol. 131, No. 1, 01.01.2013, p. 40-55.

Research output: Contribution to journalArticle

Kleinstreuer, NC, Dix, DJ, Houck, KA, Kavlock, RJ, Knudsen, TB, Martin, MT, Paul, KB, Reif, DM, Crofton, KM, Hamilton, K, Hunter, R, Shah, I & Judson, RS 2013, 'In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis', Toxicological Sciences, vol. 131, no. 1, pp. 40-55. https://doi.org/10.1093/toxsci/kfs285
Kleinstreuer, Nicole C. ; Dix, David J. ; Houck, Keith A. ; Kavlock, Robert J. ; Knudsen, Thomas B. ; Martin, Matthew T. ; Paul, Katie B. ; Reif, David M. ; Crofton, Kevin M. ; Hamilton, Kerry ; Hunter, Ronald ; Shah, Imran ; Judson, Richard S. / In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis. In: Toxicological Sciences. 2013 ; Vol. 131, No. 1. pp. 40-55.
@article{864c4ab1b5654e3eb489ce643da4b34b,
title = "In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis",
abstract = "Thousands of untested chemicals in the environment require efficient characterization of carcinogenic potential in humans. A proposed solution is rapid testing of chemicals using in vitro high-throughput screening (HTS) assays for targets in pathways linked to disease processes to build models for priority setting and further testing. We describe a model for predicting rodent carcinogenicity based on HTS data from 292 chemicals tested in 672 assays mapping to 455 genes. All data come from the EPA ToxCast project. The model was trained on a subset of 232 chemicals with in vivo rodent carcinogenicity data in the Toxicity Reference Database (ToxRefDB). Individual HTS assays strongly associated with rodent cancers in ToxRefDB were linked to genes, pathways, and hallmark processes documented to be involved in tumor biology and cancer progression. Rodent liver cancer endpoints were linked to well-documented pathways such as peroxisome proliferator-activated receptor signaling and TP53 and novel targets such as PDE5A and PLAUR. Cancer hallmark genes associated with rodent thyroid tumors were found to be linked to human thyroid tumors and autoimmune thyroid disease. A model was developed in which these genes/pathways function as hypothetical enhancers or promoters of rat thyroid tumors, acting secondary to the key initiating event of thyroid hormone disruption. A simple scoring function was generated to identify chemicals with significant in vitro evidence that was predictive of in vivo carcinogenicity in different rat tissues and organs. This scoring function was applied to an external test set of 33 compounds with carcinogenicity classifications from the EPA's Office of Pesticide Programs and successfully (p = 0.024) differentiated between chemicals classified as {"}possible{"}/{"}probable{"}/{"}likely{"} carcinogens and those designated as {"}not likely{"} or with {"}evidence of noncarcinogenicity.{"} This model represents a chemical carcinogenicity prioritization tool supporting targeted testing and functional validation of cancer pathways.",
keywords = "Bioinformatics., Cancer hallmarks, Carcinogenesis, In vitro and alternatives, Predictive toxicology",
author = "Kleinstreuer, {Nicole C.} and Dix, {David J.} and Houck, {Keith A.} and Kavlock, {Robert J.} and Knudsen, {Thomas B.} and Martin, {Matthew T.} and Paul, {Katie B.} and Reif, {David M.} and Crofton, {Kevin M.} and Kerry Hamilton and Ronald Hunter and Imran Shah and Judson, {Richard S.}",
year = "2013",
month = "1",
day = "1",
doi = "10.1093/toxsci/kfs285",
language = "English (US)",
volume = "131",
pages = "40--55",
journal = "Toxicological Sciences",
issn = "1096-6080",
publisher = "Oxford University Press",
number = "1",

}

TY - JOUR

T1 - In vitro perturbations of targets in cancer hallmark processes predict rodent chemical carcinogenesis

AU - Kleinstreuer, Nicole C.

AU - Dix, David J.

AU - Houck, Keith A.

AU - Kavlock, Robert J.

AU - Knudsen, Thomas B.

AU - Martin, Matthew T.

AU - Paul, Katie B.

AU - Reif, David M.

AU - Crofton, Kevin M.

AU - Hamilton, Kerry

AU - Hunter, Ronald

AU - Shah, Imran

AU - Judson, Richard S.

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Thousands of untested chemicals in the environment require efficient characterization of carcinogenic potential in humans. A proposed solution is rapid testing of chemicals using in vitro high-throughput screening (HTS) assays for targets in pathways linked to disease processes to build models for priority setting and further testing. We describe a model for predicting rodent carcinogenicity based on HTS data from 292 chemicals tested in 672 assays mapping to 455 genes. All data come from the EPA ToxCast project. The model was trained on a subset of 232 chemicals with in vivo rodent carcinogenicity data in the Toxicity Reference Database (ToxRefDB). Individual HTS assays strongly associated with rodent cancers in ToxRefDB were linked to genes, pathways, and hallmark processes documented to be involved in tumor biology and cancer progression. Rodent liver cancer endpoints were linked to well-documented pathways such as peroxisome proliferator-activated receptor signaling and TP53 and novel targets such as PDE5A and PLAUR. Cancer hallmark genes associated with rodent thyroid tumors were found to be linked to human thyroid tumors and autoimmune thyroid disease. A model was developed in which these genes/pathways function as hypothetical enhancers or promoters of rat thyroid tumors, acting secondary to the key initiating event of thyroid hormone disruption. A simple scoring function was generated to identify chemicals with significant in vitro evidence that was predictive of in vivo carcinogenicity in different rat tissues and organs. This scoring function was applied to an external test set of 33 compounds with carcinogenicity classifications from the EPA's Office of Pesticide Programs and successfully (p = 0.024) differentiated between chemicals classified as "possible"/"probable"/"likely" carcinogens and those designated as "not likely" or with "evidence of noncarcinogenicity." This model represents a chemical carcinogenicity prioritization tool supporting targeted testing and functional validation of cancer pathways.

AB - Thousands of untested chemicals in the environment require efficient characterization of carcinogenic potential in humans. A proposed solution is rapid testing of chemicals using in vitro high-throughput screening (HTS) assays for targets in pathways linked to disease processes to build models for priority setting and further testing. We describe a model for predicting rodent carcinogenicity based on HTS data from 292 chemicals tested in 672 assays mapping to 455 genes. All data come from the EPA ToxCast project. The model was trained on a subset of 232 chemicals with in vivo rodent carcinogenicity data in the Toxicity Reference Database (ToxRefDB). Individual HTS assays strongly associated with rodent cancers in ToxRefDB were linked to genes, pathways, and hallmark processes documented to be involved in tumor biology and cancer progression. Rodent liver cancer endpoints were linked to well-documented pathways such as peroxisome proliferator-activated receptor signaling and TP53 and novel targets such as PDE5A and PLAUR. Cancer hallmark genes associated with rodent thyroid tumors were found to be linked to human thyroid tumors and autoimmune thyroid disease. A model was developed in which these genes/pathways function as hypothetical enhancers or promoters of rat thyroid tumors, acting secondary to the key initiating event of thyroid hormone disruption. A simple scoring function was generated to identify chemicals with significant in vitro evidence that was predictive of in vivo carcinogenicity in different rat tissues and organs. This scoring function was applied to an external test set of 33 compounds with carcinogenicity classifications from the EPA's Office of Pesticide Programs and successfully (p = 0.024) differentiated between chemicals classified as "possible"/"probable"/"likely" carcinogens and those designated as "not likely" or with "evidence of noncarcinogenicity." This model represents a chemical carcinogenicity prioritization tool supporting targeted testing and functional validation of cancer pathways.

KW - Bioinformatics.

KW - Cancer hallmarks

KW - Carcinogenesis

KW - In vitro and alternatives

KW - Predictive toxicology

UR - http://www.scopus.com/inward/record.url?scp=84872386643&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872386643&partnerID=8YFLogxK

U2 - 10.1093/toxsci/kfs285

DO - 10.1093/toxsci/kfs285

M3 - Article

C2 - 23024176

AN - SCOPUS:84872386643

VL - 131

SP - 40

EP - 55

JO - Toxicological Sciences

JF - Toxicological Sciences

SN - 1096-6080

IS - 1

ER -